Why join us on a deal?
The Accelerate Fund seeks to bring multiple investors into deals and encourages collaboration among angels and other VC funds. We typically invest $250,000 as a first investment in a company, and strive to bring in angel capital that is two to three times more than the amount of the Accelerate Fund III investment.
Finding the most promising teams and technology to back takes work and network. The Accelerate Fund collaborates with good-fit investment partners that share our investment focus, and who bring value to the promising startups we’re looking to back.
We seek to bring in multiple investors into deals. We will work with other VC funds, formal angel groups, super-angels, family funds, and individual angel investors. The $23M Accelerate Fund III is managed by Yaletown Partners with support from the A100.
In some cases, Accelerate Fund can join in on deals under previously drafted terms and conditions. However, all proposed terms would be subject to review. For example, if the valuation or term sheet is drafted in such a way that it may limit future investment, a revision may be negotiated. Some additional terms of investment may also be developed.
The opportunity to secure an early round that combined angel investment and venture capital was a great fit for our stage of growth. Accelerate Fund’s openness to other angels wanting to invest in us has been key in the fit.
Key for us is scaling sales. Brad and Dave provide partnership connections and insight on potential markets and the introductions and knowledge they’ve shared has already helped extend our market reach.
We are passionate about building a successful biotech business in Alberta. The Accelerate Fund II managers, Yaletown Partners and the A100, share our passion and provide us with strategic capital.